What do we know about new cholesterol drug Lipfendra? Merck’s new once-daily drug gets FDA approval
Comments Off on What do we know about new cholesterol drug Lipfendra? Merck’s new once-daily drug gets FDA approval
July 18, 2026
The U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), a once-daily cholesterol-lowering drug developed by Merck & Co. Lipfendra, whose generic name is enlicitide, works by blocking a protein called PCSK9. This protein…